Will some virus strains causing cancer respond better to one drug more than the other (ivermectin or hydroxychloroquine)?

This is the case and provides a solid rationale for subjecting both agents to detailed studies so there is a good definition and understanding of their potential, individually and in combination, for use as therapeutic agents in these new ways.